Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of super-insecticide-resistant dengue mosquitoes in Asia: Threats of concomitant knockdown resistance mutations.
Kasai S, Itokawa K, Uemura N, Takaoka A, Furutani S, Maekawa Y, Kobayashi D, Imanishi-Kobayashi N, Amoa-Bosompem M, Murota K, Higa Y, Kawada H, Minakawa N, Cuong TC, Yen NT, Phong TV, Keo S, Kang K, Miura K, Ng LC, Teng HJ, Dadzie S, Subekti S, Mulyatno KC, Sawabe K, Tomita T, Komagata O. Kasai S, et al. Among authors: keo s. Sci Adv. 2022 Dec 21;8(51):eabq7345. doi: 10.1126/sciadv.abq7345. Epub 2022 Dec 21. Sci Adv. 2022. PMID: 36542722 Free PMC article.
One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance.
Boukli N, Flamand C, Chea KL, Heng L, Keo S, Sour K, In S, Chhim P, Chhor B, Kruy L, Feenstra JDM, Gandhi M, Okafor O, Ulekleiv C, Auerswald H, Horm VS, Karlsson EA. Boukli N, et al. Among authors: keo s. Front Med (Lausanne). 2023 Apr 24;10:1161268. doi: 10.3389/fmed.2023.1161268. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37168265 Free PMC article.
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
Lynch RC, Ujjani CS, Poh C, Warren EH, Smith SD, Shadman M, Till B, Raghunathan VM, Alig S, Alizadeh AA, Gulhane A, Chen DL, Tseng Y, Coye H, Shelby M, Ottemiller S, Keo S, Verni K, Du H, Vandermeer J, Gaston A, Rasmussen H, Martin P, Marzbani E, Voutsinas J, Gopal AK. Lynch RC, et al. Among authors: keo s. Blood. 2023 May 25;141(21):2576-2586. doi: 10.1182/blood.2022019254. Blood. 2023. PMID: 36913694 Clinical Trial.
ONE ASSAY TO TEST THEM ALL: COMPARING MULTIPLEX ASSAYS FOR EXPANSION OF RESPIRATORY VIRUS SURVEILLANCE.
Boukli N, Flamand C, Chea KL, Heng L, Keo S, Sour K, In S, Chhim P, Chhor B, Kruy L, Feenstra JDM, Gandhi M, Okafor O, Ulekliev C, Auerswald H, Horm VS, Karlsson EA. Boukli N, et al. Among authors: keo s. medRxiv [Preprint]. 2023 Jan 22:2023.01.19.23284806. doi: 10.1101/2023.01.19.23284806. medRxiv. 2023. PMID: 36711477 Free PMC article. Updated. Preprint.
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas.
Lynch RC, Poh C, Ujjani CS, Warren EH, Smith SD, Shadman M, Morris K, Lee S, Rasmussen H, Ottemiller S, Shelby M, Keo S, Verni K, Kurtz DM, Alizadeh AA, Chabon JJ, Hogan GJ, Schulz A, Gooley T, Voutsinas JM, Gopal AK. Lynch RC, et al. Among authors: keo s. Blood Adv. 2023 Jun 13;7(11):2449-2458. doi: 10.1182/bloodadvances.2022009145. Blood Adv. 2023. PMID: 36521030 Free PMC article. Clinical Trial.
26 results